Illustration (Photo:Medcom.id)
Illustration (Photo:Medcom.id)

Sinovac Covid-19 Vaccine Still Waiting for Approval from BPOM: Jokowi

English covid-19 pandemic
Nur Azizah • 06 January 2021 17:23
Jakarta: President Joko Widodo (Jokowi) is optimistic that the Sinovac Biotech covid-19 vaccine can obtain the emergeny use authorizarion (EUA) from the Food and Drug Monitoring Agency (BPOM) in the near future.
 
According to the President, the EUA is needed to start the covid-19 vaccination program in the country.
 
"We are still waiting for the results of the trials and the issuance of the approval," said President Jokowi here on Wednesday.

Bagaimana tanggapan anda mengenai artikel ini?


"We hope that is can be available this week or next weeks. I will get vaccinated one or two days after the issuance of the approval," he explained.
 
President Jokowi will be the first person to receive covid-19 vaccination in Indonesia. The move aims to ensure the public that the vaccine is safe. The former Jakarta governor is scheduled to receive covid-19 vaccine shot on January 13.
 
In a bid to achieve herd immunity, 181 million Indonesian people must get the vaccine.
 
Taking into account that one person needs two doses of vaccine, as well as guidelines from the World Health Organization (WHO) to prepare 15 percent for reserves, the total doses needed are approximately 426 million doses.
 
Besides Sinovac, Indonesia will also procure covid-19 vaccines from other producers and programs, namely Pfizer, AstraZeneca, Novavax and COVAX.
 
(WAH)
FOLLOW US

Ikuti media sosial medcom.id dan dapatkan berbagai keuntungan

Dapatkan berita terbaru dari kami Ikuti langkah ini untuk mendapatkan notifikasi

unblock notif